Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
July 27, 2020 | FDAnews
EMA Committee Recommends Dapivirine Vaginal Ring
Placed in the vagina, the silicone ring slowly releases the antiretroviral medicine dapivirine for 28 days. More »
July 27, 2020 | European Pharmaceutical Review
EMA recommends 11 new medicines for approval following July meeting
The CHMP adopted a positive opinion for Dapivirine Vaginal Ring (dapivirine), used to reduce the risk of infection with HIV-1. More »
July 27, 2020 | Daily Nation (Kenya)
Agency approves monthly vaginal ring as new HIV prevention method
A silicone vaginal ring containing antiretroviral drug dapivirine has received an agency's approval as a new HIV prevention method for women. More »
July 26, 2020 | The Sunday News (Zimbabwe)
Ring to reduce HIV by 45 percent
The dapivirine vaginal ring has been under study as an HIV preventative tool for 16 years and received a nod from the EMA. More »
July 26, 2020 | SABC News (South Africa)
Regulatory process for the roll-out of the antiretroviral ring needs to start in SA: Health Department
The National Health Department says it will start with the regulatory processes in preparation for the roll-out of the dapivirine vaginal ring in South Africa to prevent the transmission of HIV. More »